身体活動行動を修正するための登山ライフスタイル介入: パイロット研究 (CLIMB)
身体活動行動を修正するためのクライミング ライフスタイル介入 (CLIMB): パイロット研究
The aim of this pilot study is to determine the effects of a 12-week indoor rock climbing training program on heart health, mental health, and behavioral health in generally healthy adults aged 18-35 years old who do not exercise. Participants will learn to rock climb using ropes on an indoor rock climbing wall and participate in the training program 2-3 days per week for 60 minutes each session over 12 weeks. Health outcomes will be measured at 4 time points over the course of the study (pre-intervention, 6-weeks/mid-intervention, 12-weeks/post-intervention, and 24-weeks post-intervention).
調査の概要
状態
状態
条件
条件
介入・治療
介入・治療
詳細な説明
The purpose of this study is to determine the effects of a 12-week progressive, supervised indoor rock climbing intervention on physical, mental, and behavioral health outcomes in physically inactive adults. This will be a pilot study used for informing a larger, randomized controlled trial. Measurements include: cardiometabolic disease risk factors (e.g., blood pressure, fasting glucose and lipids, hemoglobin a1c), health-related components of physical fitness (e.g., cardiorespiratory fitness, muscular fitness, dynamic balance, body composition), health-related quality of life, and behavior change variables (e.g., attitudes toward physical activity, self-efficacy for exercise, objective physical activity and sedentary behavior). The majority of rock climbing-related studies focus on enhancing performance in high-level climbing athletes and very little research has examined the specific impact of climbing physical activity on cardiovascular health parameters. Indoor climbing has demonstrated to be an activity that is safe for many individuals and does not require a high level initial fitness to partake in the activity. This study will engage generally healthy, physically inactive adults (aged 18-35 y) in an indoor rock climbing program 2 times per week for 60 minutes for the first 4 weeks and progressing to 3 times per week for 60 minutes for the last 8 weeks. Participants will partake in top-rope style rock climbing and bouldering. Data collection will occur over three visits to the School of Health and Human Performance Research Lab at four time points throughout the course of the study (baseline/pre-intervention, 6-weeks/mid-intervention, 12-weeks/post-intervention, 24-weeks post-intervention; total of 12 data collection visits).
研究の種類
研究の種類
入学 (実際)
入学
段階
段階
- 適用できない
連絡先と場所
研究場所
-
-
Michigan
-
Marquette、Michigan、アメリカ、49855
- Northern Michigan University
-
-
参加基準
適格基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Physically inactive
- Membership to Physical Education Instructional Facility at Northern Michigan University
- No/very little experience with rock climbing
- No diagnosed cardiovascular, metabolic, renal disease
- No current injury
Exclusion Criteria:
- Physically active
- Experience with rock climbing
- No current membership with Physical Education Instructional Facility at Northern Michigan University
- Pregnant and/or breastfeeding
- Diagnosis of cardiovascular disease, metabolic disease, renal disease
- Current or previous injury that would be exacerbated by rock climbing
- Other diagnosed conditions in which rock climbing would be contraindicated
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:防止
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:なし(オープンラベル)
アーム数
武器と介入
参加者グループ / アーム参加者グループ / アーム |
介入・治療介入・治療 |
|---|---|
|
介入なし:Control
Participants in the control arm will be asked to maintain their current lifestyle behaviors. |
|
|
実験的:Intervention
Participants in the intervention arm will be asked to partake in a 12-week progressive, supervised, indoor rock climbing training program. |
Training will occur 2-3 days per week for 60 minutes; ratings of perceived exertion between 3-7 on a scale of 0-10 will be targeted for the desired intensity throughout the program. Minutes of rock climbing will also be monitored to develop the progression strategy. |
この研究は何を測定していますか?
主要な結果の測定
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Fasting lipids
時間枠:0, 6, 12, 24 weeks
|
HDL-c; LDL-c; total cholesterol, triglycerides measured via capillary blood sample and point-of-care testing |
0, 6, 12, 24 weeks
|
|
Fasting glucose
時間枠:0, 6, 12, 24 weeks
|
glucose (mg/dL) measured via capillary blood sample and point-of-care testing |
0, 6, 12, 24 weeks
|
|
Hemoglobin a1c
時間枠:0, 6, 12, 24 weeks
|
Glycosylated hemoglobin (%) measured via capillary blood sample and point-of-care testing |
0, 6, 12, 24 weeks
|
二次結果の測定
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Physical activity and sedentary behavior
時間枠:0, 6, 12, 24 weeks
|
Objectively monitored light, moderate, and vigorous physical activity minutes per week |
0, 6, 12, 24 weeks
|
|
Sedentary behavior bouts (30 min, 60 min, >60 min)
時間枠:0, 6, 12, 24 weeks
|
Objectively monitored number of bouts of sedentary behavior occurring in bouts of 30 minutes or less, 30-60 minutes, and greater than 60 minutes |
0, 6, 12, 24 weeks
|
|
Cardiorespiratory fitness
時間枠:0, 12 weeks
|
VO2max (mL/kg/min) measured via expired air analysis |
0, 12 weeks
|
|
Muscular fitness
時間枠:0, 12 weeks
|
Maximal isometric handgrip strength (kg) using an electronic handgrip dynamometer |
0, 12 weeks
|
|
Handgrip strength asymmetry
時間枠:0, 12 weeks
|
Maximal isometric handgrip strength measured using an electronic handgrip dynamometer on both hands |
0, 12 weeks
|
|
Lower-body dynamic balance
時間枠:0, 12 weeks
|
Lower-quarter y-balance test distance (cm) on each leg, in the anterior, posteromedial, and posterolateral directions. |
0, 12 weeks
|
|
Health-related quality of life using CDC Health-Related Quality of Life Scale
時間枠:0, 6, 12, 24 weeks
|
Core healthy days module, activity limitations module. Core healthy days module measures the number of days over the past 30 days where injury, mental health, was not good and kept individuals from performing usual activities. Activity limitations asks if individuals are limited by any health problems, how many days they are limited by health problems, and if needs are impaired. Healthy days symptom module asks if pain, depression, anxiety and sleep were an issue on any number of days over the past 30 days. Additionally, how many days individuals felt healthy and full of energy over the past 30 days. |
0, 6, 12, 24 weeks
|
|
Exercise self-efficacy measured via Self-efficacy for exercise scale
時間枠:0, 6, 12, 24 weeks
|
Self-efficacy for exercise scale is 9 items representing various scenarios that are measured on a scale of 1 (not confident) to 10 (very confident) a participant feels to exercise in that scenario. Higher scores represent higher self-efficacy for exercise participation. |
0, 6, 12, 24 weeks
|
|
Perceptions of exercise measured via Views and Attitudes Toward Exercise Scale
時間枠:0, 6, 12, 24 weeks
|
Views and attitudes towards exercise scale is 15 items measured on a 7-point Likert scale from strongly disagree (lowest) to strongly agree (highest). Sum up all responses, higher scores are better perceptions of exercise. |
0, 6, 12, 24 weeks
|
|
Perceived stress
時間枠:0, 6, 12, 24 weeks
|
Perceived stress scale items are scored from adding up each alternative over 10 items: 0=never, 1=almost never, 2=sometimes, 3=fairly often, 4=very often. 0-13=low stress, 14-26=moderate stress, 27-40=high perceived stress. |
0, 6, 12, 24 weeks
|
|
Blood pressure
時間枠:0, 6, 12, 24 weeks
|
Systolic and diastolic blood pressure (mmHg) measured via automated blood pressure cuff. |
0, 6, 12, 24 weeks
|
|
Body composition
時間枠:0, 12, 24 weeks
|
Fat free mass, fat mass in kg using Dual-energy x-ray absorptiometry |
0, 12, 24 weeks
|
|
Bone density
時間枠:0, 12, 24 weeks
|
Total bone density (g/cm3) using Dual-energy x-ray absorptiometry |
0, 12, 24 weeks
|
協力者と研究者
捜査官
捜査官
- 主任研究者:Megan C Nelson, PhD、Northern Michigan University
研究記録日
主要日程の研究
研究開始 (実際)
研究開始
一次修了 (実際)
一次修了
研究の完了 (実際)
研究の完了
試験登録日
最初に提出
最初に提出
QC基準を満たした最初の提出物
QC基準を満たした最初の提出物
最初の投稿 (実際)
最初の投稿
学習記録の更新
投稿された最後の更新 (実際)
投稿された最後の更新
QC基準を満たした最後の更新が送信されました
QC基準を満たした最後の更新が送信されました
最終確認日
最終確認日
詳しくは
本研究に関する用語
キーワード
その他の研究ID番号
その他の研究ID番号
- HS-24_51
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
This is a small pilot study; individual participant data will not be shared to protect participants information so that it remains confidential.
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。